was successfully added to your cart.

Donor Dad Shares AML Clinical Trial Success Story

We acknowledge and thank the following Link Partners for their ongoing support.

American Society for Transplantation and Cellular Therapy (ASTCT) • Barbara Ann Karmanos Cancer Institute • Blood and Marrow Transplant Program at Northside Hospital • Center for International Blood and Marrow Transplant Research (CIBMTR) • City of Hope • Dana-Farber/ Brigham and Women’s Cancer Center • DKMS • Froedtert & the Medical College of Wisconsin Cancer Network • Henry Ford Stem Cell Transplant & Cellular Therapy Program • Incyte Corporation • Memorial Sloan Kettering Cancer Center • Meredith A. Cowden Foundation • Nebraska Medicine • Oregon Health & Science University Knight Cancer Center • Roswell Park Comprehensive Cancer Center • Seattle Cancer Care Alliance • Siteman Cancer Center at Barnes-Jewish Hospital/Washington University School of Medicine • Spectrum Health Cancer Center • Stem Cell Transplantation and Cellular Therapy Program, John Theurer Cancer Center at Hackensack University Medical Center • The Leukemia & Lymphoma Society • University Hospitals Seidman Cancer Center • Vanderbilt-Ingram Cancer Center

This month’s telephone educational and support program will highlight the story of a donor dad who stopped at nothing to save his daughter, Kenza, diagnosed with acute myeloid leukemia (AML) at just nine months old. Dr. Omar Durani of Dallas, Texas will talk about Kenza’s life-saving clinical trial five years ago, his family today, the need to spread the word to create much needed awareness through DKMS, and his incredible haplo donor experience. Leah Szumita, MS, RN, CCRN, ACNS-BC, Director, Clinical Trials Support Center of The Leukemia & Lymphoma Society will join Dr. Durani and further emphasize the importance of clinical trials and how to better understand and navigate them. The nbmtLINK’s licensed staff social worker, Jennifer Gillette, will facilitate the program. There will also be plenty of time for live questions.